Centro Hospitalar de Sao Joao - Hospital de Sao Joao

Porto 4200-319

2 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Crohn's Disease, Inflammatory Bowel Diseases, Ulcerative Colitis, Ulcerative Colitis Chronic

Studies at this site

• A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01) — Recruiting now
• A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON) — Recruiting now